Study 2016-63 (Collaboration) IMI Project

Ongoing study - PREFER is a public-private collaborative research project under the Innovative Medicines Initiative (IMI). The objective of PREFER is to establish recommendations to support the development of guidelines for industry, Regulatory Authorities and HTA bodies on how and when to include patient preferences on benefits and risks of medical products in their decision making processes (www.imi-prefer.eu).

The project encompasses decision making processes alongside the entire medical product lifecycle, from discovery to reimbursement and post-marketing surveillance.

Published on: 
2019/09/04